Emily Titus

Senior Vice President, Technical Operations • Notch Therapeutics

Emily obtained her PhD from the Institute of Biomaterials and Biomedical Engineering at the University of Toronto, where she used a combination of laboratory and bioinformatics approaches to define and interpret gene regulatory networks controlling embryonic stem cell fate decisions. At Notch, she oversees the Technical Operations function, which includes Process and Analytical Development, Manufacturing Sciences, Engineering and Project Management. Previously, she held the position of Vice President, Technology Advancement at CCRM, where she built cell reprogramming, genome engineering and pluripotent stem cell differentiation programs and led the company incubation program that culminated in the launch of Notch Therapeutics.


Also Speaking

David Sourdive

Co-Founder and Executive Vice President CMC & Manufacturing • Cellectis

Matthew Hewitt

Executive Director, Scientific Services, Cell and Gene Therapy • Charles River

Jacqueline Barry

Chief Clinical Officer • Cell and Gene Therapy Catapult

Also Speaking


Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.


Find out more and apply to get involved at the briefings taking place at Advanced Therapies Week.